News & Updates

In patients hospitalized for severe COVID-19, adding the plant flavonoid quercetin to the antiviral drugs remdesivir or favipiravir reduced hospitalization period and levels of inflammatory markers related to the pathogenesis of SARS-CoV-2, thus preventing the progression of the disease into its critical phase, suggests an open-label study from Iran.

While the strict and rapid implementation of border restrictions, contact tracing, case isolation, social-distancing, and quarantine protocols can effectively suppress COVID-19 transmission, densely populated environments, as in the case of migrant worker dormitories in Singapore, remain at risk of outbreaks, according to a recent study.

A registry-based study has recently shown diverse COVID-19 vaccine-associated dermatologic reactions, including papulovesicular, pityriasis rosea-like, and papulosquamous eruptions classified as vaccine-related eruption of papules and plaques (V-REPP).

Ocular morbidity and visual outcomes are poor in patients with clinical presumed concomitant microbial and herpes simplex keratitis, a recent study has found.

A recent study has reported that women from non-Western countries are at increased risk of genital infections. Younger age also contributes to a risk increase, while living outside of larger cities seems to have a protective effect.

Individuals who have undergone bariatric surgery to treat obesity may have a reduced risk of developing severe COVID-19, according to a recent study.